Fundamentally Applied: from lab to patients with Caroline Demangel

The “Fundamentally Applied” videos feature testimonials from researchers at the Institut Pasteur (which is a Carnot Institute), whose work has led to the development of healthcare products.
In this 4th episode, Caroline Demangel, Head of Immunobiology and Therapy Unit at the Institut Pasteur, explains how the study of a toxin from a mycobacterium responsible for a tropical disease called Buruli ulcer, has led to the identification of a potential new therapeutic target for the treatment of multiple myeloma.
Her work is carried out in collaboration with the startup studio Argobio.